Product Information
NATROBA 0.9% TOPICAL SUSP is a brand product labeled by ParaPRO LLC, priced at $2.2020 per ML under NDC 52246092904. Its NADAC has been published 663 times since Jan 22, 2014.
FDA first approved this application on Jan 18, 2011.
Strength
9 mg/mL
Manufacturer
ParaPRO LLCNDC
52246092904
Classification
Brand
Dosage Form
SUSPENSION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
SPINOSADApproval Type
New Drug (NDA)
FDA Application
NDA022408FDA Approved
1/18/2011
On Market Since
1/25/2011
Pharmacological Classes
Price Statistics
The NADAC for NATROBA 0.9% TOPICAL SUSP has been published 663 times since Jan 22, 2014, and over the history we have for it it has risen 16.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2020 per ML |
|---|---|
| All-time high | $2.2120 (Aug 12, 2020) |
| All-time low | $1.7821 (May 21, 2014) |
| 52-week high | $2.2047 |
| 52-week low | $2.2020 |
| Median price | $2.2002 |
| Average price | $2.1037 |
| Largest weekly change | -7.7% (May 21, 2014) |
| Weeks tracked | 663 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ParaPRO LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
spinosad market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Pediculicide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NATROBA 0.9% TOPICAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for NATROBA 0.9% TOPICAL SUSP, manufactured by ParaPRO LLC, is $2.2020 per ML (NDC 52246092904), effective Sep 30, 2026.
How has the price of NATROBA 0.9% TOPICAL SUSP changed over time?
Over the history we have for it, the NADAC for NATROBA 0.9% TOPICAL SUSP has risen 16.6%. It has been tracked across 663 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for NATROBA 0.9% TOPICAL SUSP?
Since Jan 22, 2014, the NADAC for NATROBA 0.9% TOPICAL SUSP has ranged from a low of $1.7821 (May 21, 2014) to a high of $2.2120 (Aug 12, 2020), with a median of $2.2002 per ML.
Are there cheaper alternatives to NATROBA 0.9% TOPICAL SUSP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SPINOSAD 0.9% TOPICAL SUSP, is $2.0169 per ML — about 8% below NATROBA 0.9% TOPICAL SUSP.
Who manufactures NATROBA 0.9% TOPICAL SUSP?
NATROBA 0.9% TOPICAL SUSP (NDC 52246092904) is labeled by ParaPRO LLC, and CMS classifies it as a brand product.